Skip to content

BHI Therapeutic Sciences Jamaica

Dedicated to the research and development of stem cell therapies to treat and manage diseases…

  • About Us
    • IRB Approved Protocols
  • Leadership
    • Scientific Advisory Board
  • About Stem Cells
  • Research Applications
    • Summary of FDA studies conducted by BHI Therapeutic Sciences/COVID-19
    • IRB Approved Protocols
    • Chronic Inflammation, Anti-aging, Back Pain
    • Spinal Cord Injury
    • Stroke
    • Musculoskelatal Conditions: Osteoarthritis, Rheumatoid Arthritis
    • Other Indications
      • Amyotrophic Laterasl Sclerosis (ALS)
      • Alzheimer’s Disease (AD)
      • Autoimmune Diseases
      • Traumatic Brain Injury
      • Cardiovascular Disease
      • Cerebral Palsy (CP)
      • Diabetes Mellitus
      • Hypoxia
      • Reproductive System and Sexual Disorders
      • Macular Degeneration
      • Mood Disorder
      • Multiple Sclerosis (MS)
      • Renal Disease
      • Sickle-Cell Disease (SCD)
      • Stem Cell Regenerative Skin and Scalp Treatment
      • Thalassemia
  • Procedure Overview
    • Safety of Stem Cell Therapy
    • Stem Cell Therapy Process
    • Privacy Policy
    • Patient Forms
  • Why Jamaica?
  • Testimonials
  • Photo Gallery
  • News
  • Events
  • BHI Stem Cells
  • Donations
  • Invest
  • Stem Cell Q&A Group
  • Contact Us
Posted on November 12, 2020November 12, 2020 by bluehorizon

Stem Cell Guru- Episode 4

Categoriesnews

Post navigation

Previous PostPrevious Paper from BHI Therapeutic Sciences and Blue Horizon International, Slovakia Published in the Journal of Clinical Medicine Research
Next PostNext Brian Mehling, M.D. presented at the Neuroscience 20 | SBMT virtual summit on November 21, 2020

Search

About This Site

This may be a good place to introduce yourself and your site or include some credits.

  • Email
Proudly powered by WordPress